Blood Vessels Lecture Audio Recording 4

Big Picture: Maintaining Circulatory Homeostasis

  • Goal: Keep arterial blood pressure (BP) and blood volume (BV) within a narrow range so tissues receive adequate perfusion.
  • Two broad response timescales
    • Short-term (seconds–minutes) – Autonomic/SNS adjustments of cardiac output (CO) and total peripheral resistance (TPR).
    • Long-term (minutes–hours–days) – Endocrine mechanisms that alter renal water & Na⁺ handling, erythrocyte number, and thirst-driven intake.
  • Foundational cardiovascular equations alluded to or implied
    • BP=CO×TPRBP = CO \times TPR
    • CO=HR×SVCO = HR \times SV
  • Context links
    • Builds on earlier endocrine-system lecture (renin–angiotensin axis, ADH, aldosterone).
    • Integrates with previous cardiovascular talks on baroreceptor-mediated SNS reflexes.

When BP/BV DROP

1. Fast Autonomic Compensation
  • ↓BP/↓BV → Baroreceptor unloading → Sympathetic activation
    • Cardio-acceleratory center fires → ↑HR → ↑CO.
    • Vasomotor center fires → systemic arteriolar vasoconstriction → ↑TPR.
    • Catecholamine surge (epinephrine & norepinephrine) from adrenal medulla augments both effects.
  • Immediate objective: raise BP quickly while endocrine system ramps up.
2. Renin–Angiotensin–Aldosterone System (RAAS)
  • Trigger: Juxtaglomerular cells in kidney detect ↓renal perfusion/pressure → release renin.
  • Biochemical cascade
    1. Renin cleaves circulating angiotensinogen (from liver) → angiotensin I.
    2. Pulmonary (& endothelium-derived) ACE converts angiotensin I → angiotensin II (ANG IIANG\,II).
  • Effects of ANG IIANG\,II
    • Potent systemic vasoconstrictor → ↑TPR.
    • Stimulates adrenal cortex → aldosterone.
    • Stimulates posterior pituitary → ADH (vasopressin).
    • Activates hypothalamic thirst centers.
  • Resulting renal & behavioral outcomes
    • Aldosterone: ↑Na⁺ reabsorption (distal nephron) → obligatory H₂O reabsorption → ↑BV.
    • ADH: Inserts aquaporin-2 in collecting ducts → ↑free-water reabsorption → ↑BV; also mild vasoconstriction.
    • Thirst: Increased oral water intake → expands extracellular fluid (ECF) volume.
  • Net effect: Gradual restoration of both BV & BP ("homeostasis restored").
3. Erythropoietin (EPO) – Hemorrhage-specific adjunct
  • Conditional release: Only when ↓BP/BV is the result of blood loss (hemorrhage).
  • Source: Peritubular capillary endothelial cells in kidney.
  • Action: Stimulates red-bone-marrow erythropoiesis → ↑RBC mass → restores O₂-carrying capacity compromised by acute bleed.
  • Takes days to weeks but critical for full recovery of oxygen delivery.
4. Integrated Outcome for Low-Pressure Scenario
  • SNS: ↑CO + ↑TPR
  • RAAS: ↑BV + some ↑TPR
  • EPO: ↑RBCs (long-term).
  • Cumulative aim: normalize arterial pressure & circulating volume while ensuring adequate oxygenation.

When BP/BV RISE

Cardiac Natriuretic Peptides (ANP & BNP)
  • Stimulus: Stretch of atrial (ANP) & ventricular (BNP) walls due to ↑venous return/↑BV.
  • Molecular players
    • Atrial Natriuretic Peptide (ANP).
    • Brain-type Natriuretic Peptide (BNP) (also produced in ventricles).
  • Endocrine effects (essentially the mirror-image inhibition)
    • Suppress RAAS
    • ↓Renin release → ↓ANG II.
    • Directly inhibit aldosterone secretion.
    • Down-regulate ADH release.
    • Blunt SNS output
    • Inhibit adrenal catecholamine release (epinephrine, norepinephrine).
    • Promote systemic vasodilation (↓TPR).
  • Renal & systemic consequences
    • Natriuresis – ↑Urinary Na⁺ excretion.
    • Diuresis – ↑H₂O excretion (follows Na⁺).
    • Reduced thirst – Dampened hypothalamic drive.
    • Net: ↓BV → ↓venous return → ↓CO; vasodilation → ↓TPR.
  • Clinical relevance: Elevated BNP is a diagnostic marker in congestive heart failure (reflects chronic ventricular stretch).

Comparative Summary Table (Narrative Form)

  • ↓BP/BV
    • Fast: SNS → ↑HR, ↑SV, ↑CO, vasoconstriction.
    • Endocrine: Renin → ANG II → ADH + Aldosterone + Thirst; Hemorrhage-specific EPO.
  • ↑BP/BV
    • Cardiac stretch → ANP/BNP → Inhibit ADH, Aldosterone, Epi, Nor-epi → Natriuresis, Diuresis, Vasodilation.

Conceptual Connections & Implications

  • Redundancy & synergy – Multiple overlapping systems ensure BP/BV stability; failure of one can be compensated by the others (e.g., chronic renal impairment blunts RAAS, so SNS & vasopressin play larger roles).
  • Clinical tie-ins
    • ACE inhibitors, ARBs, & aldosterone antagonists treat hypertension by blocking RAAS.
    • Synthetic BNP (nesiritide) once used for acute decompensated heart failure to promote diuresis.
  • Ethical/pharmacological note – Doping with recombinant EPO can dangerously elevate hematocrit → ↑blood viscosity → ↑thrombotic risk.

Step-by-Step Flowcharts (Text Version)

Low BP/BV
  1. ↓Baroreceptor firing → CNS triggers SNS response.
  2. Kidneys: ↓Perfusion → Renin.
  3. Renin → ANG I.ANG\,I.
  4. Lungs/ACE → ANG II.ANG\,II.
  5. ANG IIANG\,II → ADH + Aldosterone + Thirst.
  6. Hemorrhage? → Kidney releases EPO.
  7. Results: Vasoconstriction + ↑HR + Fluid retention + RBC synthesis → ↑BP/BV.
High BP/BV
  1. ↑Atrial/ventricular stretch → ANP/BNP.
  2. ANP/BNP → ↓Renin, ↓Aldosterone, ↓ADH, ↓SNS.
  3. Kidneys excrete Na⁺ & H₂O.
  4. Vasodilation maintained.
  5. Results: ↓BV → ↓BP.

Key Take-Home Messages

  • The body treats low pressure/volume as an emergency, activating both neural (seconds) and hormonal (minutes to days) countermeasures.
  • RAAS is the centerpiece of long-term volume regulation; its activation influences virtually every fluid-handling organ/system.
  • Natruiretic peptides act as the physiological brake, ensuring pressure/volume do not overshoot.
  • EPO is unique – only deployed in bleed-induced hypovolemia to restore O₂-carrying capacity, not merely volume.